Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

More in Pharmacists

Sovaldi, Gilead Sciences Inc.‘s hepatitis C drug which currently costs $1,000 per pill, will be available in 91 developing nations at a lower cost, a Reuters article reports. Roughly 150 million people in the world have chronic hepatitis C; few of...
Vyvanse, an ADHD drug produced by Shire is receiving a priority review for the potential treatment of binge eating disorder, a Reuters article reports. The review comes after the FDA approval of Orexigen Therapeutic‘s obesity pill Contrave....
Contrave, a new diet pill that hopes to combat obesity has received FDA approval, a Reuters article says.  The drug, which is made by Orexigen Therapeutics Inc, combines an antidepressant with the anti-drug dependence pill, naltrexone. Contrave is the...